Valuation: PetIQ, Inc.

Market Cap 919M 799M 744M 683M 1.29B 87.74B 1.31B 8.77B 3.44B 43.68B 3.45B 3.38B 146B P/E 2022
-5.58x
P/E 2023 282x
Enterprise Value 1.27B 1.1B 1.03B 944M 1.78B 121B 1.81B 12.12B 4.76B 60.41B 4.77B 4.67B 203B EV / Sales 2022
0.69x
EV / Sales 2023 0.84x
Free-Float
91.62%
Yield 2022 *
-
Yield 2023 -
3 years 15.09
Extreme 15.09
31.06
5 years 6.66
Extreme 6.66
35.8
10 years 6.66
Extreme 6.66
46
Manager TitleAgeSince
Chief Executive Officer 55 2025-02-16
Director of Finance/CFO 62 2022-01-02
President 48 2022-05-31
Director TitleAgeSince
Director/Board Member 70 2024-10-24
Director/Board Member - 2024-10-24
Director/Board Member - 2024-10-24
Date Insider Type Main position Quantity % Market Cap.
10/25/24 Issuer sale

Director

10,180 0.0343%
10/25/24 Issuer sale

Director

22,650 0.0763%
10/25/24 Issuer sale

Director

18,925 0.0638%
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%-.--%-.--%+90.88% 919M
+1.66%+2.57%-47.56%-57.53% 32.4B
-0.34%+5.86%+91.23%+124.81% 13.17B
+0.48%+5.65%-15.72%+0.96% 3.84B
-1.17%+1.66%-0.74%+22.50% 3.25B
+7.85%+12.96%+48.36%+23.56% 2.04B
-1.45%+0.74%+2.10%+20.14% 1.89B
-0.33%+6.74%+39.14%+144.48% 1.47B
+1.73%+9.59%-20.13%-8.98% 1.14B
+1.24%+4.31%-13.95%-45.82% 989M
Average +0.96%+4.51%+8.27%+31.50% 6.11B
Weighted average by Cap. +1.04%+3.75%-4.56%+3.00%

Financials

2022 2023
Net sales 922M 801M 746M 685M 1.29B 87.97B 1.31B 8.79B 3.45B 43.79B 3.46B 3.38B 147B 1.1B 958M 892M 819M 1.55B 105B 1.57B 10.51B 4.12B 52.37B 4.14B 4.05B 176B
Net income -48.21M -41.91M -39.01M -35.81M -67.63M -4.6B -68.68M -460M -180M -2.29B -181M -177M -7.68B 2.13M 1.85M 1.72M 1.58M 2.99M 203M 3.04M 20.32M 7.98M 101M 8M 7.83M 340M
Net Debt 371M 322M 300M 275M 520M 35.38B 528M 3.54B 1.39B 17.62B 1.39B 1.36B 59.07B 352M 306M 285M 261M 494M 33.6B 501M 3.36B 1.32B 16.73B 1.32B 1.29B 56.08B
Logo PetIQ, Inc.
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
Employees
1,527
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. PETQ Stock